About Wild Card
Don’t wait for a game-changer
Become one
We create new business ventures from teams and individuals with great solutions – people who are not afraid to defy convention, take a risk and with our help, create products and services that could change people’s lives.
About Wild Card
The Challenges
Choose your challenge
Calling all inventors, creators and self-starters – we challenge you to improve the health of people and patients in Europe.
Can you transform...
Early Detection of Cancer
How to advance early diagnosis and screening of cancer?
Learn moreCan you transform...
Mental Health
How to improve prevention, detection, diagnosis, and treatment to fight mental disorders?
Learn moreThe Process
Become a Wild Card
The annual call is open to innovators who want to change the course of their future and ours. Wild Card provides world-class training and mentoring, and the opportunity to create a venture with up to €1.5 million investment (grant-for-option).
HOW TO APPLY
15 DECEMBER 2021 - 14 MARCH 2022
Apply
Apply with or without a big idea if you have clinical expertise, top technical skills or business know-how combined with a passion for the challenge topics.
6 JUNE - 8 JULY 2022
Deep Dive
Admitted participants start the journey, complete their teams and with support of mentors develop a business proposal and pitch to secure their place in the next stage.
23 AUGUST - 24 OCTOBER 2022
Validate
Shortlisted teams begin a 9-week programme led by industry experts to validate the business proposals and pitch to the EIT Health Panel in late October 2022.
JANUARY 2023
Venture
Up to two chosen teams will receive EIT Health support, resources and €1.5 million investment (grant-for-option) over the next two years to develop and establish their businesses.
Wild Cards
Meet the Wild Cards
Discover the ventures Wild Card has invested in and be inspired by their founders – innovators who started off like you – who built their new company through the Wild Card journey.
Wild Cards
NaturaLens
There is an urgent need for novel cost- effective and non-invasive approaches for management of myopia and dry eye to avoid visual impairment and blindness. Our solution, a bioengineered natural contact lens (NaturaLens), can help address this underserved need.
View Wild Card
PeriVision
PeriVision wants to reimagine glaucoma monitoring to benefit patients and doctors alike by offering a portable and AI-based perimetry device for 70% faster, patient-friendly and much more cost-efficient glaucoma patient monitoring.
View Wild Card
Orbit Health
Orbit has developed Neptune, a device-agnostic AI solution regulating treatment dosage for Parkinson's disease patients, restoring patient function and quality of life. Neptune offers to patients up to 5 extra symptom-free hours per day.
View Wild Card
Wild Card
MiMARK
MiMARK sets to provide in vitro diagnostic tool based on the determination of 5 protein biomarkers in uterine fluid samples to provide a diagnosis to 100% of patients, to rule out endometrial cancer with great specificity, and provide information on a histological subtype of the tumour to guide surgical treatment.
View Wild Card
Wild Card
Abtrace
Every use of an antibiotic comes with a risk that resistance might develop. Abtrace is using artificial intelligence to tackle AMR – perhaps the greatest global health threat of our time.
View Wild Card
Wild Card
Smart4Diagnostics
Digital innovations are taking diagnostics from a trust-based system into an accurate, evidence-based system. Smart4Diagnostics closes the data gap between blood collection and lab analysis.
View Wild Card
Wild Card
iLoF
Harnessing biophotonics and artificial intelligence to unlock new possibilities in Alzheimer’s drug discovery. iLoF is creating a pathway which promotes breakthroughs in Alzheimer's disease research.
View Wild Card
Wild Card
PIPRA
Disorientation, memory loss and speech difficulties are some of the symptoms of post-operative cognitive complications in the over-60s. PIPRA, short for Pre-interventional Preventative Risk Assessment, is developing a risk score in-app intervention for pre and post-operative patients.
View Wild CardIncubators
This is only the beginning
The two chosen ventures will embed themselves in a Wild Card incubator of their choosing in Europe. Wild Card is not just a project, teams will need to relocate and focus full-time on building their new start-up with support from EIT Health, the largest healthcare network in Europe.
News & Events
Read the latest news and events from Wild Card.
See all News & Events
We asked the Wild Card class of 2020 to get real with us and tells us what they thought of our first fully virtual Wild Card. The response was utterly thorough and humblingly positive leaving us with lots to digest. Here comes our attempt to do so!
Read more
EIT Health has announced their support for two innovator teams following the 2020 Wild Card programme, selecting MiMARK and Orbit Health.
Read more
iLoF as one of the top 150 digital health companies worldwide by CB Insight's
iLoF gains global recognition by CB Insight's. Wild Card portfolio company has been listed as one of the most promising digital health companies in the world in 2020 ranking
Read more